Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02472184 · ClinicalTrials.gov registry record · NA
Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy
A NA study of Uterine Fibroids and Vaginal Bleeding, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
- 1
- Study location
NCT02472184: Completed NA study of Uterine Fibroids and Vaginal Bleeding, sponsored by University of South Florida.
NCT02472184 is a NA study of Uterine Fibroids and Vaginal Bleeding that has completed, run by University of South Florida. The registered enrollment target is 78 participants, below the 236-participant average among 10 other Uterine Fibroids trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02472184, a NA study of Uterine Fibroids and Vaginal Bleeding, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will look at the optimal order in which to perform concurrent office hysteroscopy and endometrial biopsy in female patients who present for evaluation of abnormal uterine bleeding at a fibroid and endometriosis treatment center.
Primary Outcome
After the procedures are performed, the patient will be asked to describe their pain perception based on Visual analogue scale (VAS) from 0-10
Conditions Studied
Interventions
- PROCEDURE Endometrial biopsy
- PROCEDURE Office hysteroscopy
Study Locations (1)
Florida
- University of South Florida College of Medicien Department of Obstetrics and Gynecology - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-03 |
| Phase | NA |
What the finished NCT02472184 record still lists
NCT02472184 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 236-participant average among 10 other Uterine Fibroids trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with Uterine Fibroids appearing as the primary indexed condition, and to 2 interventions - of which Endometrial biopsy is the first listed.
NCT02472184 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02472184 about?
NCT02472184 is a clinical study titled "Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy". This study will look at the optimal order in which to perform concurrent office hysteroscopy and endometrial biopsy in female patients who present for evaluation of abnormal uterine bleeding at a fibroid and endometriosis treatment center.
What is the current status of trial NCT02472184?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2015-10. Estimated completion is 2017-03.
What conditions does trial NCT02472184 study?
This clinical trial studies the following conditions: Uterine Fibroids, Vaginal Bleeding.
What interventions are being tested in trial NCT02472184?
The interventions under investigation include: Endometrial biopsy (PROCEDURE), Office hysteroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02472184?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02472184 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uterine Fibroids
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02472184's enrollment target sits among peer trials
78 4th of 10 higher than 7 of 10 other Uterine Fibroids trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Uterine Fibroids trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
RECRUITING · NA
-
Uterine Leiomyoma Treatment With Radiofrequency Ablation
COMPLETED · NA
-
Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids
COMPLETED · NA
-
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
RECRUITING · Phase 3
-
Effect of Addition of Steroids on Duration of Analgesia
ACTIVE NOT RECRUITING · Early Phase 1
-
Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia